ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

AACR’s First Special Conference Scheduled for Oct. 23-27 at Cape Cod

July 22, 1988

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013